S&P Futures
5,887.50 -8.75 (-0.15%) Dow Futures
43,131.00 -46.00 (-0.11%) Nasdaq Futures
20,472.50 -47.00 (-0.23%) Russell 2000 Futures
2,250.30 -5.20 (-0.23%) Crude Oil
70.30 -0.26 (-0.37%) Gold
2,744.60 +5.70 (+0.21%)
Omega Therapeutics, Inc. (OMGA)
After hours:
| Previous Close | 1.0600 |
| Open | 1.0800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.0400 - 1.0800 |
| 52 Week Range | 0.8900 - 6.3000 |
| Volume | |
| Avg. Volume | 200,251 |
| Market Cap | 59.016M |
| Beta (5Y Monthly) | 1.84 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4200 |
| Earnings Date | Aug 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.14 |
GlobeNewswireOmega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will share new preclinical data at three upcoming scientific meetings. “These preclinical results build upon the foundation of data we have shared to date and expand our confidence in the ability of epigenomic controllers to upregulate or downregulate th
PR NewswireInvaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the appointment of André Andonian as the new Chairman of its Board of Directors. Robert Berendes has decided to step down after serving as Chairman of the Board since 2019 and will continue to serve on the board of Invaio.
